Astrocytic Target Mechanisms in Obesity

肥胖中的星形胶质细胞靶机制

• 批准号: 9281242
• 负责人: Yunlei Yang
• 金额: $ 42.85万
• 依托单位: UPSTATE MEDICAL UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2017
• 资助国家: 美国
• 起止时间: 2017-08-01 至 2018-04-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/9281242
• 关键词: ART protein; Adenosine; Adenosine A1 Receptor; Adenosine Kinase; Appetite Stimulants; Astrocytes; Biological Assay; Biology; Brain; Cause of Death; Clinical; Data; Development; Diet; Disease; Eating Disorders; Electrophysiology (science); Elements; Energy Intake; Energy Metabolism; Expenditure; Goals; High Fat Diet; Homeostasis; Hypothalamic structure; Measurement; Metabolic; Methods; Molecular; Mus; Neurobiology; Neurons; Obese Mice; Obesity; Pathologic Processes; Pathology; Pharmacology; Play; Process; Receptor Signaling; Regulation; Reporting; Research; Role; Signal Transduction; Societies; Structure of nucleus infundibularis hypothalami; Synapses; Testing; Therapeutic; Time; Treatment Efficacy; Work; base; cell type; chemical genetics; effective therapy; energy balance; experimental study; extracellular; feeding; genetic approach; in vivo; insight; kinase inhibitor; neural circuit; neuroregulation; novel; obesity treatment; optogenetics; prevent; receptor; reduced food intake; relating to nervous system; therapeutic target

Project Summary Obesity and its associated complications impose a huge burden to our society. However, the mechanisms underlying this disorder and its related pathologies remain unclear, and effective treatments are still lacking. At its core, obesity results from an imbalance between energy intake and energy expenditure. Most work has focused on neural regulation of energy balance, however, an important but poorly understood element is the role played by astrocytes in the regulation of energy states although they play crucial functions in regulating synaptic strength and neural activity. To further our understanding of the processes of obesity and to seek effective therapeutics, it is necessary to consider astrocytic influence on energy homeostasis and determine the underlying mechanisms. Our long-term goal is to enable the development of novel targets to correct diet-induced obesity (DIO). Our overall objective for this application is to determine the ability of hypothalamic astrocytes to correct DIO and determine the mechanisms of that correction. Our central hypothesis is that astrocyte can react to and negatively regulate energy surfeit in DIO by reducing the synaptic strength at orexigenic agouti-related protein (AgRP) neurons in arcuate nucleus (ARC) in mice, which will be achieved by elevating extracellular adenosine. Our hypothesis has been formulated on the basis of our recent study and our preliminary data that astrocyte activation reduces feeding and silences AgRP neurons via adenosine A1 signaling, induces energy expenditure, and elevates extracellular adenosine. The rational for the proposed research is that, once it is known how astrocytes regulate energy states, it may be feasible to manipulate them pharmacologically to correct or reverse obesity, and potentially a variety of eating disorders. To accomplish our goals, we have assembled a research team that combines a diverse range of expertise including glial biology, neurobiology, and energy metabolism. To test our central hypothesis and thereby accomplish our overall objective, we will carry out three Specific Aims: (1) Determine how astrocytes control synaptic strength at AgRP neurons; (2) Determine how astrocytes contribute to synaptic alterations during (HFD) feeding; (3) Identify astrocytic target in the treatment of HFD-induced obesity (DIO). Experiments proposed here will be examined using a multifaceted approach that includes cell type-specific electrophysiology, chemogenetic- and optogenetic astrocytic manipulation, time-lapse deep-brain measurements of adenosine, temporal control of pharmacology, and metabolic assays. Adenosine augmentation therapy in obesity will also be performed with an integrated chemical and genetic approach to target adenosine kinase inhibitor to arcuate astrocytes. Results using these cutting-edge methods will give us unprecedented access to understanding glial control of energy states. Together, the proposed research represents a new and substantial departure from other studies in that it shifts the focus to developing astrocytic targets for obesity treatment.

项目摘要 肥胖及其相关的并发症给我们的社会带来了巨大负担。但是， 该疾病及其相关病理的基础机制尚不清楚，有效的治疗方法是 仍然缺乏。肥胖的核心是由于能量摄入和能量消耗之间的不平衡而导致的。 但是，大多数工作都集中在能量平衡的神经调节上，但是这是一个重要但知之甚少的 元素是星形胶质细胞在能量状态调节中扮演的角色，尽管它们起着关键功能 在调节突触强度和神经活动中。为了进一步了解肥胖过程和 为了寻求有效的治疗学，有必要考虑对能量体内稳态和 确定基本机制。我们的长期目标是使新目标的发展 正确饮食引起的肥胖症（DIO）。我们对此应用的总体目标是确定 下丘脑星形胶质细胞纠正DIO并确定该校正的机制。我们的中心 假设是，星形胶质细胞可以通过减少突触 小鼠的弧形核（ARC）中的甲状体Agouti相关蛋白（AGRP）神经元的强度，这将是 通过升高细胞外腺苷实现。我们的假设是根据我们最近的基础提出的 研究和我们的初步数据，星形胶质细胞激活可减少喂养和通过 腺苷A1信号传导，诱导能量消耗并提高细胞外腺苷。理性的 拟议的研究是，一旦知道星形胶质细胞如何调节能量状态，则可能是可行的 在药理学上操纵它们以纠正或逆转肥胖症，并可能有多种饮食失调。 为了实现我们的目标，我们组建了一个研究团队，将各种各样的范围结合在一起 专业知识，包括神经胶质生物学，神经生物学和能量代谢。测试我们的中心假设和 从而实现我们的整体目标，我们将执行三个具体目标：（1）确定星形胶质细胞如何 AGRP神经元的控制突触强度； （2）确定星形胶质细胞如何促进突触改变 在（HFD）进食期间； （3）在治疗HFD诱导的肥胖症（DIO）中确定星形细胞靶标。实验 此处提出的将使用包括细胞类型特异性电生理学的多面方法检查， 化学发生和光遗传学的星形胶质细胞操纵，腺苷的延时深度测量， 药理学和代谢测定的时间控制。肥胖症的腺苷增强疗法也将 用靶向腺苷激酶抑制剂的综合化学和遗传方法进行弓形 星形胶质细胞。使用这些尖端方法的结果将使我们史无前例地访问理解神经胶质 能量状态的控制。拟议的研究一起代表了与 其他研究将重点转移到开发肥胖治疗的星形细胞靶标。